Welcome

Who attends?

The 2011 event is expected to attract around 200-250 senior level attendees. The following charts show the profile of the 2010 attendees.

Geographic Breakdown

Seniority

•Europe – 71%
•North America – 25%
•RoW – 4%

• President / Chairman/ Managing Director / CXO – 30%
• Vice President / Senior Vice President / Executive Vice President – 18%
• Director / Executive Director / Partner – 33%
• Manager / Senior Manager –14%
• Other (eg. academics)/unknown – 5%

Industry Breakdown

Function

• Pharma / biotech – 53%
•Suppliers of products and services – 21%
•Government / academic / NGOs – 15%
Analysts / investors •4%
•Consultants / lawyers – 6%
•Press – 1%

• R&D – 44%
Corporate Management – 21%
• Business Development / Corporate Development / Licensing / Sales & • Marketing – 20%
• Regulatory – 4%
• Other/unknown – 2%

For 2011, we will be aiming our marketing campaign at the following key individuals within vaccine/active immunotherapeutic developers/manufacturers and technology companies:

CEOs, COOs, Presidents, Managing Directors & Board Members
Vice Presidents, Directors and Senior Managers of Licensing, Business Development, Corporate Development, Marketing and Strategy & Planning
CSOs and Vice Presidents, Directors and Senior Managers of R&D, Research, Development, Preclinical Research, Clinical Research, Project Management and Product Development
Vice Presidents, Directors and Senior Managers of Regulatory Affairs, Government Affairs and Public Affairs
and
Vice Presidents, Directors and Senior Managers of Manufacturing, Process Development and Technical Development

And don’t forget, all attendees will have access to the conference sessions during both agendas as well as to the shared exhibition area, where all networking activities will be centered. Sponsors may target one attendee profile or the other – or both – and all exhibitors will enjoy high levels of access to participants in both programmes.

“NMT found the pre-event networking services of invaluable use..."

Read More»